Does DUPILUMAB Cause Psychomotor hyperactivity? 43 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Psychomotor hyperactivity have been filed in association with DUPILUMAB (Dupixent). This represents 0.0% of all adverse event reports for DUPILUMAB.
43
Reports of Psychomotor hyperactivity with DUPILUMAB
0.0%
of all DUPILUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Psychomotor hyperactivity From DUPILUMAB?
Of the 43 reports, 5 (11.6%) required hospitalization.
Is Psychomotor hyperactivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DUPILUMAB. However, 43 reports have been filed with the FAERS database.
What Other Side Effects Does DUPILUMAB Cause?
Pruritus (44,279)
Dermatitis atopic (33,670)
Product use in unapproved indication (33,452)
Rash (30,895)
Injection site pain (27,799)
Drug ineffective (23,712)
Dry skin (20,239)
Eczema (20,020)
Product dose omission issue (18,189)
Condition aggravated (16,459)
What Other Drugs Cause Psychomotor hyperactivity?
METHYLPHENIDATE (617)
QUETIAPINE (412)
ARIPIPRAZOLE (389)
OLANZAPINE (366)
SERTRALINE (288)
MONTELUKAST (282)
RISPERIDONE (277)
LEVETIRACETAM (247)
VENLAFAXINE (214)
LEVOTHYROXINE (211)
Which DUPILUMAB Alternatives Have Lower Psychomotor hyperactivity Risk?
DUPILUMAB vs DURAGESIC
DUPILUMAB vs DUROGESIC
DUPILUMAB vs DUROTEP MT
DUPILUMAB vs DURVALUMAB
DUPILUMAB vs DUTASTERIDE